Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: dwight martin who wrote (11338)	8/17/1999 3:25:00 PM
From: Tassi	Respond to of 17367

I am sure XOM will post some news after the close today, but I don't expect very good one "No news is a good news maybe". I will hold until tomorrow good luck..

To: dwight martin who wrote (11338)	8/17/1999 3:29:00 PM
From: LJM	Respond to of 17367

No damage control whatsoever from Xoma...Why??? More than likely, elements of truth slipped through from Ellen, unintentionally. The risk/reward scenario has changed today and I regrettably adjusted my holdings accordingly. This is not how I thought this would play out at all. After 4 long years, I did not expect to have to deal with this bloomberg nonsense. I could live with the CC, but this bloomberg report is still out there and the company sits silent. What else is one to think? Hear goes Tom Costello on CNBC repeating again <<"Xoma stock is down and we know why,... yesterday Xoma found out the FDA may not let them pursue approval of their experimental drug Neuprex">> I think this is the 5th time I've heard him repeat this!! LJM